Hwaseong-si, South Korea

Seok Jong Kang

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Okcheon-gun, KR (2015 - 2017)
  • Hwaseong-Si, KR (2013 - 2022)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Seok Jong Kang: Innovator in Cancer Treatment

Introduction

Seok Jong Kang is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 10 patents to his name, Kang's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents are innovative pyrimidine compounds and pharmaceutical compositions aimed at preventing or treating various cancers. These patents detail a pyrimidine compound represented by a specific formula, a method for preparing the compound, and its pharmaceutical applications for cancer prevention and treatment. This research highlights the importance of his contributions to oncology.

Career Highlights

Seok Jong Kang has worked with notable companies in the pharmaceutical industry, including Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to his successful patent applications.

Collaborations

Kang has collaborated with esteemed colleagues such as Kwee Hyun Suh and In Hwan Bae. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Seok Jong Kang's work in developing pyrimidine compounds for cancer treatment showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to innovation that has the potential to benefit many patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…